Vertex Pharmaceuticals Incorporated (VRTX), headquartered in Boston, Massachusetts, is a global leader in biotechnology and ...

Vertex Pharmaceuticals Inc. closed $111.56 below its 52-week high ($519.88), which the company achieved on November 8th.

This was the stock's third consecutive day of gains.

Vertex is a company specializing in consulting services and tax preparation software. S&P 500 components Fortinet and Boston Scientific are among five stocks to watch near buy points as 2024 comes ...

These generic granules are equivalent to Vertex Pharmaceuticals' 'Kalydeco' oral granules in the same strengths.

After hours: January 8 at 4:42:19 PM EST Loading Chart for VERX ...

Vertex Securities Ltd., incorporated in the year 1993, is a Small Cap company (having a market cap of Rs 41.37 Crore) operating in Financial Services sector. Vertex Securities Ltd. key ...

GEN uncovers seven biopharma-related trends based on interviews with experts and other industry stakeholders, as well as ...

By the end of March, the regulator could clear a highly anticipated pain drug from Vertex and a heart drug that’s critical to Alnylam’s future.